肥厚型心肌病节段性心肌纤维化与微循环障碍之间的关系研究

吴明星; 黄泽旭; 慕家盛; 王晓炎; 肖华; 孙琦; 陈启稚

doi:10.13201/j.issn.1001-1439.2021.09.012

肥厚型心肌病节段性心肌纤维化与微循环障碍之间的关系研究

- 1. 上海交通大学医学院附属第九人民医院心内科(上海, 200011);
- 2. 上海交通大学医学院附属第九人民医院放射科
基金项目:
上海交通大学医学院附属第九人民医院临加项目(No:JYLJ201803)

详细信息

通讯作者: 陈启稚,E-mail:qizhi_chen@126.com

中图分类号: R542.2

收稿日期: 2021-03-25

Relationship between segmental myocardial fibrosis and coronary microvascular dysfunction in hypertrophic cardiomyopathy

- 1. Department of Cardiology, Shanghai Ninth People's Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, 200011, China;
- 2. Department of Radiology, Shanghai Ninth People's Hospital, Shanghai Jiaotong University School of Medicine

More Information

Corresponding author: CHEN Qizhi, E-mail: qizhi_chen@126.com

Received Date: 25 March 2021

摘要

摘要: 目的:应用心脏磁共振(CMR)技术评估并探索肥厚型心肌病(HCM)心肌组织特征与局部微血管功能之间的关系。方法:入选2018年1月—2019年12月在我院由心脏超声确诊的HCM患者23例(HCM组),健康志愿者19例(对照组)。所有研究对象均完成CMR检查,包括左心室短轴电影成像、T1 mapping成像及静息心肌首过灌注成像等。应用第三方专业软件CVI42分析图像,分析得出左心室心功能参数、整体以及16个心肌节段(美国心脏病协会左室心肌分段法)的Native T1值和静息心肌灌注参数:最大信号强度(SI-max),最大信号强度所对应的时间(Time-max),心肌信号强度的最大斜率(Slope-max),并比较对照组和HCM组之间的差异。将HCM组的心肌节段(378段)分为HCM纤维化节段(Native T1≥1288 ms, 150段)和HCM非纤维化节段(Native T1<1288 ms, 228段)两个亚组,比较其与对照组心肌节段之间静息心肌灌注参数的差异。结果:相比较于对照组,HCM组的整体Native T1值和Time-max延长,Slope-max和SI-max下降(P<0.005);较对照组节段和HCM非纤维化节段,HCM纤维化节段Slope-max、SI-max显著降低,Time-max明显增加(P<0.005);此外,HCM非纤维化节段中Slope-max较对照组节段降低,Time-max较对照组节段增加,且差异也具有统计学意义。结论:CMR可用于早期检测HCM患者的微循环障碍和心肌纤维化。微循环障碍同时存在于HCM纤维化和非纤维化节段,这表明了在心肌发生纤维化之前,其微循环功能已经受损。
- 肥厚型心肌病 /
- 微循环障碍 /
- 纤维化 /
- 心肌核磁共振
Abstract: Objective: To evaluate and explore the relationship between cardiac tissue characteristic and local micro-vascular function in hypertrophic cardiomyopathy(HCM) by Cardiovascular magnetic resonance(CMR).Methods: The 23 HCM patients(HCM group) diagnosed by echocardiography in our hospital from January 2018 to December 2019 and 19 healthy volunteers(control group) were enrolled. All cases underwent CMR including short axis cine, T1 mapping imaging and first-pass myocardial perfusion. Cvi42, a third-party image processing software, was applied to analyze images. Perfusion parameters were assessed, including maximal signal intensity(SI-max), time to maximal signal intensity(Time-max), maximal upslope of myocardial intensity enchantment(Slope-max), the cardiac function parameters, the Native T1 value of 16 myocardial segments of left ventricular, as well as of the global myocardium. The 378 segments in HCM group were divided into HCM fibrotic segments(Native T1≥1288 ms, N=150) and HCM non-fibrotic segments(Native<1288 ms, N=228). The differences in perfusion parameters were compared among control group segments, HCM fibrotic segments and HCM non-fibrotic segments.Results: The global Native T1 and Time-max prolonged, but Slope-max and SI-max decreased in HCM group when comparing with control group(P<0.001). Compared with HCM non-fibrotic segments and control group segments, the Slope-max and SI-max decreased, and Time-max increased in HCM fibrotic segments(P<0.005). Additionally, the Slope-max and Time-max also showed statistically significant difference between HCM non-fibrotic segments and control group segments(all P<0.001).Conclusion: CMR could facilitate the early evaluation of coronary microvascular dysfunction and fibrosis in HCM.
- hypertrophic cardiomyopathy /
- coronary microvascular dysfunction /
- fibrosis /
- cardiovascular magnetic resonance

HTML全文

参考文献(30)

[1]	Kogut J,Popjes ED.Hypertrophic cardiomyopathy2020[J].Curr Cardiol Rep,2020,22(11):154.
[2]	Malahfji M.Examining the impact of inducible ischemia on myocardial fibrosis and exercise capacity in hypertrophic cardiomyopathy[J].Sci Rep,2020,10(1):15977.
[3]	Zhou Y.Predictive values of apelin for myocardial fibrosis in hypertrophic cardiomyopathy[J].Int Heart J,2019,60(3):648-655.
[4]	Camici PG.Coronary microvascular dysfunction in hypertrophy and heart failure[J].Cardiovasc Res,2020,116(4):806-816.
[5]	Con N.Contrast-free detection of myocardial fibrosis in hypertrophic cardiomyopathy patients with diffusion-weighted cardiovascular magnetic resonance[J].JCardiovasc Mag Reson,2015,17:107.
[6]	Chatzantonis G.Diagnostic value of the novel CMRparameter "myocardial transit-time"(MyoTT)for the assessment of microvascular changes in cardiac amyloidosis and hypertrophic cardiomyopathy[J].Clin Res Cardiol,2021,110(1):136-145.
[7]	Yon W.Plasma level of big endothelin-1predicts the prognosis in patients with hypertrophic cardiomyopathy[J].Int J Cardiol,2017,243:283-289.
[8]	Kobayashi Y.Time based versus strain based myocardial performance indices in hypertrophic cardiomyopathy,the merging role of left atrial strain[J].Eur Heart J Cardiovasc Imaging,2019,20(3):334-342.
[9]	Yang C.Procollagen type I carboxy-terminal propeptide(PICP)and MMP-2are potential biomarkers of myocardial fibrosis in patients with hypertrophic cardiomyopathy[J].Cardiovasc Pathol,2019,43:107150.
[10]	Fujita T.Increased extent of myocardial fibrosis in genotyped hypertrophic cardiomyopathy with ventricular tachyarrhythmias[J].J Cardiol,2015,66(1):63-68.
[11]	Fujimoto K.Incremental value of left atrial active function measured by speckle tracking echocardiography in patients with hypertrophic cardiomyopathy[J].Echocardiography,2018,35(8):1138-1148.
[12]	Son O.New appearance of fragmented QRS as a predictor of ventricular arrhythmic events in patients with hypertrophic cardiomyopathy[J].Circ J,2020,84(3):487-494.
[13]	谢明星,王睿,张丽.多模态影像在心脏疾病诊疗中的应用与进展[J].临床心血管病杂志,2020,36(12):1071-1074.
[14]	Peng J.Normal values of myocardial deformation assessed by cardiovascular magnetic resonance feature tracking in a healthy chinese population:a multicenter study[J].Front Physiol,2018,9:1181.
[15]	Kowallick JT.Quantification of left atrial strain and strain rate using Cardiovascular Magnetic Resonance myocardial feature tracking:a feasibility study[J].JCardiovasc Magn Reson,2014,16:60.
[16]	Da K.An epidemic of dyssynchrony:but what does it mean?[J].JACC,2008,51(1):12-17.
[17]	Akoglu H.User's guide to correlation coefficients[J].Turk J Emerg Med,2018,18(3):91-93.
[18]	Evin M.Assessment of left atrial function by MRImyocardial feature tracking[J].J Magn Reson Imaging,2015,42(2):379-389.
[19]	Pon B.Left atrial relaxation and left ventricular systolic function determine left atrial reservoir function[J].Circulation,1999,100(4):427-436.
[20]	Jalanko M.Left ventricular mechanical dispersion is associated with nonsustained ventricular tachycardia in hypertrophic cardiomyopathy[J].Ann Med,2016,48(6):417-427.
[21]	向春红.初始T1值和细胞外容积分数与弥漫性心肌纤维化的相关性:Meta分析[J].临床心血管病杂志,2020,36(12):1093-1098.
[22]	Aon AR.Prevalence and progression of late gadolinium enhancement in children and adolescents with hypertrophic cardiomyopathy[J].Circulation,2018,138(8):782-792.
[23]	Tfon H.Strain echocardiography is related to fibrosis and ventricular arrhythmias in hypertrophic cardiomyopathy[J].Euro Heart J Cardiovasc Imaging,2016.17(6):613-621.
[24]	Xu J.MRI T1Mapping in hypertrophic cardiomyopathy:evaluation in patients without late gadolinium enhancement and hemodynamic obstruction[J].Radiology,2020,294(2):275-286.
[25]	Muser D.Prevalence,correlates,and prognostic relevance of myocardial mechanical dispersion as assessed by feature-tracking cardiac magnetic resonance after a first ST-segment elevation myocardial infarction[J].Am J Cardiol,2017,120(4):527-533.
[26]	KH H.Mechanical dispersion assessed by myocardial strain in patients after myocardial infarction for risk prediction of ventricular arrhythmia[J].JACC Cardiovascular imaging,2010,3(3):247-256.
[27]	Ron H.Prognostic value of left atrial function by cardiovascular magnetic resonance feature tracking in hypertrophic cardiomyopathy[J].Int J Cardiovasc Imaging,2019,35(6):1055-1065.
[28]	Eon D.Mechanical dispersion:the simple,robust parameter,we are looking for Value for the hypertrophic cardiomyopathies[J].Euro Heart J Cardiovasc Imaging,2016,17(6):622-623.
[29]	Raman B.Progression of myocardial fibrosis in hypertrophic cardiomyopathy:mechanisms and clinical implications[J].Eur Heart J Cardiovasc Imaging,2019,20(2):157-167.
[30]	郭晓琳,王爱玲.84例肥厚型心肌病患者的临床特点和治疗分析[J].安徽医学,2015(7):837-840.